Citi Pharma Shareholders Approve Memorandum Change for Cannabis and Hemp Business
Citi Pharma shareholders have approved an amendment to the company’s Memorandum of Association, allowing it to undertake cannabis, industrial hemp and medicinal cannabis activities subject to regulatory approvals.
Pakistan and China Sign $440 Million Pharmaceutical Sector Agreements Under CPEC Framework
Pakistan and China finalize nine business agreements worth $440 million to boost pharmaceutical manufacturing, vaccine development, and regional medical exports.